Renal Hemodynamic Function and RAAS Activation Over the Natural History of Type 1 Diabetes

Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes

Christoph Wanner, Silvio E. Inzucchi, John M. Lachin et al. · New England Journal of Medicine · 2016 · 3.6K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Renal Hemodynamic Effect of Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 1 Diabetes Mellitus

David Z.I. Cherney, Bruce A. Perkins, Nima Soleymanlou et al. · Circulation · 2013 · 1.3K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Liraglutide and Renal Outcomes in Type 2 Diabetes

Johannes F.E. Mann, David D. Ørsted, Kirstine Brown‐Frandsen et al. · New England Journal of Medicine · 2017 · 1.2K citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +17

Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension.

Roberto Zatz, B R Dunn, Timothy W. Meyer et al. · Journal of Clinical Investigation · 1986 · 1.2K citations · Full text

Medicine, Endocrinology, Nephrology +17

Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease

Dick de Zeeuw, Tadao Akizawa, Paul Audhya et al. · New England Journal of Medicine · 2013 · 994 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17